Russia's proposed tobacco product regulation and licensing requirements

Apr.14.2023
Russia's proposed tobacco product regulation and licensing requirements
Russia proposes mandatory licenses for tobacco products and raw materials, effective from September 1, 2023.

On April 12th, the "Proposal on State Regulation of the Production and Circulation of Tobacco Products, Tobacco Industry Products, Nicotine-Containing Products and Their Raw Materials" (No. 310882-8, hereinafter referred to as "the Proposal") was passed in the first reading by the State Duma of Russia.


The following are the original text and Chinese translation of the relevant proposal by 2FIRSTS.


Classification of Mandatory Licensing Types


The first section of Article 8 of the proposal stipulates mandatory licensing requirements for the production and sale of tobacco products, nicotine-containing products, and raw materials used to produce such products.


What kinds of tobacco products are specifically covered by the license? Which stages require specific licenses? Is a license required for the import and export of products? Liang Jiasen, a market researcher for 2FIRSTS in Russia, provided a professional interpretation of the proposal.


According to the first part of Article 8 in general terms, activities related to the production and sale of tobacco products, nicotine-containing products, and materials utilized in the production of these products require a license.


The production, storage, and supply of tobacco products, raw materials, nicotine-containing products, and raw materials for the production, storage, and supply of tobacco products and nicotine-containing products are involved in their import and export within the Russian Federation. The circulation of raw materials and nicotine-containing raw materials is also included in their import and export within the Russian Federation. Additionally, the purchase of tobacco products and nicotine-containing products for use as duty-free trade under customs procedures, as well as the production, storage, and supply of cigars and related activities are included.


Experts Interpret


According to Liang Jiasen, a market researcher at 2FIRSTS, the first item on the license refers to a "raw material production license" for the production, storage, and supply of tobacco products, raw materials, nicotine-containing products, and nicotine raw materials. Such a license is required at every stage of the raw material production process.


Regarding the second provision on "production, storage and supply of tobacco products and products containing nicotine," this license is known as a "product manufacturing license," which is required for all stages of production for such products.


In relation to the third point regarding the circulation of tobacco and nicotine-containing products entering and exiting the Russian Federation, the license referred to is the "Product Import License". This license is necessary for the importation of such products into Russia and must be presented at all relevant stages of the process.


In relation to the fourth item on the import and export of raw materials and nicotine raw materials into and out of the Russian Federation, the license required is the "Raw Material Import License", which is necessary for the importation of such products into Russia. This license is required for all relevant import processes in Russia.


Regarding the fifth provision which pertains to the production, storage, and supply of cigars, it is identified as the "Cigar Production License" of the Russian Federation.


Regarding the sixth provision, which pertains to the purchase of tobacco and nicotine-containing products for sale as duty-free goods under customs procedures, this clause is part of the Russian Federation's "License for the Circulation of Duty-Free Tobacco and Nicotine products.


Scheduled to take effect on September 1st, 2023.


If the proposal is ultimately passed through the Russian legislative process, it will come into effect on September 1, 2023, with the mandatory licensing provisions outlined in Section 8, Part 1 of the proposal to be implemented on the same date. Holding a license will become a requirement from March 1, 2024. If tobacco manufacturers are found to not have a license, to have their license suspended or revoked, their production equipment will be ordered to be sealed.


2FIRSTS will continue to interpret and provide further details on laws and related content.


Topic: Progress and Expert Analysis on Russia's Ban on Flavored E-cigarettes (Click the Image Below to Jump)


Expert Analysis Series:


Expert analysis 1: The ban on flavored e-cigarettes in Russia includes all products, and the specific standards for additives have yet to be disclosed.


Expert analysis 2: Russia sets minimum retail price for e-cigarettes to reduce demand for nicotine products.


Further Reading:


Manufacturers of nicotine products in Russia now need to apply for a license following the approval of a draft law during its first reading.


Timeline and Background of Russia's Taste Ban Law Passed in Three Readings in One Day


On September 1st, a ban on flavor additives in e-cigarettes in Russia will take effect. The proposal text is available in reference 3. On April 11th, a proposal to ban flavored e-cigarettes in Russia will undergo its first discussion.


Russia proposes to impose a maximum fine of 500,000 rubles on those who sell electronic cigarettes to minors.


What is the progress in the ban on flavored products in the Russian legislative process?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
Wang Gongcheng, deputy administrator of China’s State Tobacco Monopoly Administration, met KT&G Chief Operating Officer Lee Sang-hak in Shanghai on September 1, according to Oriental Tobacco News. The meeting comes as China seeks public comment on a draft mandatory national standard for heated cigarettes. The report did not disclose the subjects discussed or indicate whether heated tobacco products or market access were addressed.
News
Sep.02
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24